Hepatobiliary and pancreatic infections in AIDS: Part one

AIDS Patient Care and STDs

Volumn 12, Issue 5, 1998, Pages 347-357

  Keaveny, Andrew P ^a   Karasik, Michael S ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ETHAMBUTOL; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; HEPATITIS B VACCINE; INTERFERON; ISONIAZID; ITRACONAZOLE; LAMIVUDINE; MACROLIDE; PENTAMIDINE; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMYCIN; STREPTOMYCIN; SULFADIAZINE; TIABENDAZOLE; TUBERCULOSTATIC AGENT;

BARTONELLACEAE; CANDIDIASIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATOBILIARY SCINTISCANNING; HEPATOBILIARY SYSTEM INFECTION; HERPES SIMPLEX VIRUS; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER FUNCTION TEST; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; PNEUMOCYSTIS CARINII; PROTOZOAL INFECTION; REVIEW; STRONGYLOIDES STERCORALIS; SYMPTOMATOLOGY;

EID: 0031802116     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.347     Document Type: Review

References (90)

1. Keaveny AP, Karasik MS, Afdhal NH. In: LaMont JT, ed. Gastrointestinal Infections. New York: Marcel Dekker, 1996:361-395.
2. Cappell MS. Hepatobiliary manifestations of the acquired immunodeficiency syndrome. Am J Gastroenterol 1991;86:1-15.
3. Schneiderman DJ. Hepatobiliary abnormalities of AIDS. Gastroenterol Clin North Am 1988;17:615-630.
4. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotrophic viruses. Clin Infect Dis 1994;18: 339-347.
5. Saini S. Imaging of the hepatobiliary tract. N Engl J Med 1997;336:1889-1894.
6. Radin R. HIV infection: Analysis in 259 consecutive patients with abnormal CT findings. Radiology 1995;197:712-722.
7. AGA Technical Review: Malnutrition and cachexia, chronic diarrhea and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996;111:1724-1752.
8. Poles MA, Dieterich DT, Schwarz ED, et al. Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV). J AIDS 1996;11: 170-177.
9. Schneiderman DJ, Arenson DM, Cello JP, et al. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 1987;7: 925-930.
10. Churchill DR, Mann D, Coker RJ, et al, Fatal hemorrhage following liver biopsy in patients with HIV infection. Genitourin Med 1996;72:62-64.
11. Barish MA, Yucel EK, Soto JA, et al. MR cholangiopancreatography: efficacy of three dimensional turbo spin echo technique. Am J Roentgenol 1995;165:295-300.
12. Quinn D, Pocock N, Freund J, et al. Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis. Clin Nucl Med 1992;18: 417-422.
13. Jeffers LJ, Alzate I, Aguilar H, et al. Laparoscopic and histologic findings in patients with the human immunodeficiency virus. Gastrointest Endosc 1994;40: 160-164.
14. Lebovics E, Dworkin BM, Heier SK, Rosenthal WS. The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol 1988;83:l-7.
15. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991;163:454-459.
16. McNair ANB, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 1992;12:188-196.
17. Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: A study of 150 homosexual men. J Infect Dis 1989;160:557-582.
18. Rustgi VK, Hoofnagle JH, Gerin JL, et al. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:795-797.
19. Levy P, Marcellin P, Martinot-Peignoux M, et al. Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology 1990;12:570-574.
20. Homan C, Krogsgaard K, Pedersen C, et al. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J AIDS 1991;4:416-420.
21. Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B. Lancet 1993;342:1175.
22. McDonald JA, Caruso L, Karayiannis P, et al. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant Interferon. Hepatology 1987;719-723.
23. Brook MG, Chan G, Yap I, et al. Randomised controlled trial of lymphoblastoid interferon alfa in Eu ropean men with chronic hepatitis B virus infection. Br Med J 1989;299:652-656.
24. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336: 347-356.
25. Schnittman SM, Pierce PF. Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type I. Clin Infect Dis 1996;23: 638-639.
26. Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109:101-105.
27. Loke RHT, Murray-Lyon IM, Coleman JC, et al. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: An indicator of poor prognosis. J Med Virol 1990;31:109-111.
28. Bruguera M, Cremades M, Salinas R, et al. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 1992; 14:27-30.
29. Zylberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996;23:1117-1125.
30. Cribier B, Rey D, Schmitt C, et al. High hepatitis C viremia and impaired antibody response in patients coinfected with HIV. AIDS 1995;9:1131-1136.
31. Sherman KE, O'Brien J, Gutierrez AC, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993;31:2679-2682.
32. Sabin CA, Telfer P, Phillips AN, et al. The association between hepatitis C virus genotype and human immunodeficiency virus progression in a cohort of hemophilic men. J Infect Dis 1997;175:164-168.
33. Eyster ME, Diamondstone LS, Lien J-M, et al. for the Multicenter Hemophilia Cohort Study. Natural History of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. J AIDS 1993;6:602-610.
34. Biehoff E, Fischer H-P, Willsch E, et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch 1997;430:271-277.
35. Soto B, Sánchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an usually rapid progression to cirrhosis. J Hepatol 1997;26:l-5.
36. Hammer SM, Squires KE, Hughes MD, et al. Controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733.
37. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337:734-739.
38. Fried MW, Hoofnagle JH. Therapy of hepatitis C. Semin Liver Dis 1995;15;82-91.
39. Soriano V, Garcia-Samaniego J, Bravo R, et al. Interferon α for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;23:585-591.
40. Causse X. Chronic hepatitis C should be treated even among HIV patients. Hepatology 1997;26:312A.
41. Zylberberg H, Chaix M-L, Rabian P, et al. Anti-HIV therapy does not influence HCV replication. Hepatology 1997;26:411A.
42. Troisi CL, Hollinger FB, Hoots WK, et al. A multicenter study of viral hepatitis in a United States hemophiliac population. Blood 1993;81:412-418.
43. Shattock AG, Finlay H, Hillary IB. Possible reactivation of hepatitis D with chronic Δ antigenaemia by human immunodeficiency virus. B Med J 1987;294: 1656-1657.
44. Grippon P, Ribiers O, Cadranel JF, et al. Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients. Lancet 1987; 1(8540):1031.
45. Eyster ME, Sanders JC, Battegay M, DiBisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 1995;40:1583.
46. dePouplana M, Soriano V, Samaniego JG, et al. More severe source of delta hepatitis in HIV infected patients. Genitourinary Med 1995;71:132-133.
47. Madejon A, Cotonat T, Bartolome J, et al. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: Utility of polymerase chain reaction in monitoring the anti-viral response. Hepatology 1994;19:1331-1336.
48. Rizzetto M. Systemic virosis producing hepatitis occasionally, or as an opportunistic infection in the immunocompromised host. In: McIntyre N, Benhamou J-P, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Hepatology. Oxford, England: Oxford University Press, 1991:635-638.
49. Bach N, Theise ND, Schaffner F. Hepatic histopathology in the acquired immunodeficiency syndrome. Semin Liver Dis 1992;12:205-212.
50. Blanshard C, Benhamou Y, Dohin E, et al. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: A randomized comparison. J Infect Dis 1995;172:622-628.
51. Karasik MS, Afdhal NH. Small and large bowel infections in AIDS. In: LaMont JT, ed. Gastrointestinal Infections. New York: Marcel Dekker, 1996:191-245.
52. Benson CA. Disease due to Mycobacterium avium complex in patients with AIDS: Epidemiology and clinical syndrome. Clin Infect Dis 1994;18(suppl 3): 218-222.
53. MacDonell KB, Glassroth J. Mycobacterium avium complex and other nontuberculous mycobacteria in patients with HIV infection. Semin Respir Infect 1989;4:123-132.
54. Sesin GP, Manzi SF, Pacheco R. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection. Am J Health-Syst Pharm 1996;53:2585-2590.
55. Prego V, Glatt AE, Thelmo W, et al. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med 1990;150:333-336.
56. Emler S, Bottger EC, Broers B, et al. Growth-deficient mycobacteria in patients with AIDS: Diagnosis by analysis of DNA amplified from blood or tissue. Clin Infect Dis 1995;20:772-775.
57. Horsburgh CR Jr. Advances in the prevention and treatment of Mycobacterium avium disease. N Engl J Med 1996;335:428-430.
58. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol and clarithromycin versus rifampin, ethambutol, clofazimine and ciprofloxacin. N Engl J Med 1996;335:377-383.
59. Farber HW, Barber TW. Mycobacterial infections. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual, 3rd ed. Boston: Little, Brown, 1995:309-324.
60. Pitchenik AE, Fertel D. Tuberculosis and nontuberculosis mycobacterial disease. Med Clin North Am 1992;76:121-171.
61. Diamond RD. The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev Infect Dis 1991;13:480-486.
62. Sugar AM, Saunders CA. Cryptococcosis. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual, 3rd ed. Boston: Little, Brown, 1995:325-335.
63. Viviani MA. Opportunistic fungal infections in patients with acquired immune deficiency syndrome. Chemotherapy 1992;38(suppl 1):35-42.
64. Stevens DA. Coccidioidomycosis. N Engl J Med 1995;332:1077-1082.
65. Ampel NM, Dols CL, Galgiani JN. Coccidioidmycosis during human immunodeficiency virus infection: Results of a prospective study in a coccidiodal endemic area. Am J Med 1993;94:235-240.
66. Daar ES, Meyèr RD. Bacterial and fungal infections. Med Clin North Am 1992;76:173-203.
67. Johnson PC, Khardori N, Najjar AF, et al. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:152-158.
68. Pastakia B, Shawker TH, Thaler M, et al. Hepatosplenic candidiasis: Wheels within wheels. Radiology 1988;2:417-421.
69. Sulis CA. Candidiasis. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual, 3rd ed. Boston: Little, Brown, 1995:399-407.
70. Sachs JR, Greenfield SM, Sohn M, Turner JL. Disseminated Pneumocystis carinii infection in a patient with the acquired immune deficiency syndrome. Am J Gastroenterol 1991:86:82-85.
71. Hagopian WA, Huseby JS. Pneumocystis hepatitis and choroiditis despite successful aerosolized pentamidine pulmonary prophylaxis. Chest 1989;96:949-951.
72. Viner BL. Pneumocystis pneumonia. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual, 3rd ed. Boston: Little Brown, 1995:275-308.
73. Fishman EK, Magid D, Kuhlman JE. Pneumocystis carinii involvement of the liver and spleen: CT demonstration. J Comput Assist Tomogr 1990;14:146-148.
74. Lubat E, Megibow AJ, Balthazar EJ, et al. Extrapulmonary Pneumocystis carinii infection in AIDS: CT findings. Radiology 1990;174:157-160.
75. Richie JL, Yamaguchi E, Virani N, et al. Extrapulmonary Pneumocystis infection. Ann Intern Med 1989;111:339-340.
76. Currier JS, Sulis CA. Toxoplasmosis. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual, 3rd ed. Boston: Little, Brown, 1995:337-347.
77. Mastroianni A, Coronado O, Scarani P, et al. Liver toxoplasmosis and acquired immunodeficiency syndrome. Rec Prog Med 1996;87:353-355.
78. Cook GC. Strongyloides stercoralis hyperinfection syndrome: How often is it missed? Q J Med 1987;64: 625-629.
79. Rawat B, Simons ME. Strongyloides stercoralis hyperinfestation: Another cause of focal hepatic lesions. Clin Imaging 1993; 17:274-275.
80. Treadwell TL. Gastrointestinal parasites. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual, 3rd ed, Boston: Little, Brown, 1995:409-417.
81. Schwartzman WA. Bacillary angiomatosis and parenchymal peliosis: frequent absence of mucocutaneous lesions. Clin Infect Dis 1996;22:801-802.
82. Mohle-Boetani JC, Koehler JE, Berger TG, et al. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: Clinical characteristics in a case-control study. Clin Infect Dis 1996;22:794-800.
83. Koehler JE, Sanchez MA, Garrido CS, et al. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med 1997;337:1876-1883.
84. Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infection: A new zoonosis with the domestic cat as reservoir. JAMA 1995;271:531-535.
85. Tompkins LS. Of cats, humans, and bartonella. N Engl J Med 1997;337:1916-1917.
86. Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1993;17: 612-624.
87. Garcia-Tsao G, Panzini L, Yoselevitz M, et al. Bacillary peliosis hepatitis as a cause of acute anemia in a patient with the acquired immunodeficiency syndrome. Gastroenterology 1992;102:1065-1070.
88. Slater LN, Welch DF, Min K-W. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med 1992;152:602-606.
89. Steeper TA, Rosenstein H, Weiser J, et al. Bacillary epithelioid angiomatosis involving the liver, spleen, and skin in an AIDS patient with concurrent Kaposi's sarcoma. Am J Clin Pathol 1992;97:713-718.
90. Case 1-1998 of the case reports of the Massachusetts General Hospital. N Engl J Med 1998;338:112-119.